Oncologic Emergencies 472
HYPERCALCEMIA OFMALIGNANCY 472
HYPERVISCOSITYSYNDROME 473
NEUTROPENICFEVER 474
SPINALCORDCOMPRESSION 474
SUPERIORVENACAVASYNDROME 475
TUMORLYSISSYNDROME 475
Dermatologic Manifestations of Malignancy 476
ANCANTHOSIS NIGRICANS 476
DERMATOMYOSITIS 476
ERYTHEMAMULTIFORME 476
ERYTHEMANODOSUM 476
ERYTHRODERMA 476
ICHTHYOSIS 477
PRURITUS 477
SISTERMARYJOSEPHNODE 477
URTICARIA 477
PURPURA 477
Multiple Myeloma 477
Hypersensitivity Reactions 477
ANAPHYLAXIS ANDANAPHYLACTOIDREACTIONS 478
ANGIOEDEMA 479
URTICARIA(HIVES) 480
SERUMSICKNESS 480
Inflammatory Disorders 481
REITER’SSYNDROME 481
SYSTEMICLUPUSERYTHEMATOSUS 481
VASCULITIS 482
Transplant Rejection 483
RENALTRANSPLANT 484
LUNGTRANSPLANT 484
HEARTTRANSPLANT 484
LIVERTRANSPLANT 485
Infection in Transplant Recipients 485
INFECTIONS IN THEFIRSTMONTH 485
INFECTIONSFROMFIRST TOSIXTHMONTH 485
INFECTIONSAFTER6 MONTHS 486
Immunodeficiency/Immunosuppression 486
ANTIBODY-MEDIATEDIMMUNEDYSFUNCTION 486
CELLULARIMMUNEDYSFUNCTION 486
NEUTROPENIA 487
MEDICALTHERAPIES 487
DIABETESMELLITUS 487